FDA Investigator Samir C Gala
Samir C Gala has inspections in 5 countries as of 29 Sep 2023. Samir C Gala has collaborated with a combinined 1611 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
22
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Netherlands,
Germany,
Spain
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Alan P Kurtzberg,
Alberto A Viciedo,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Annemarie B Randow,
Annemarie Bodnar,
Anthony C Warchut,
Anthony C Warren,
Ariel Cruz Figueroa,
Atul J Agrawal,
Brenna L Macdowell,
Cassandra L Abellard,
Cheryl A Clausen,
Chhaya S Shetty,
Daniel J Grabicki,
Daniel J Roberts,
Dawn L Wydner,
Diane C Thibodeau,
Diane M Prince,
Dien N Nguyen,
Dominic R Frasca,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Emily J Schramm,
Erik W Koester,
Frederick Razzaghi,
Gam S Zamil,
Guerlain Ulysse,
Helen Verdel,
James R Birkenstamm,
Janet A Rajan,
Janete F Guardia,
Jay B Shah,
Jeffrey J Thibodeau,
Jill M Sooter,
Jill Mielziner,
Jogy George,
John P Mistler,
Jonah S Ufferfilge,
Jonathan S Helfgott,
Jose M Cayuela,
Josh Renzon Ramilo,
Jot R Klena,
Joy Rkozlowski Klena,
Justine Tomasso,
Karen E D'orazio,
Karishma G Gopaul,
Kelli F Dobilas,
Kristy A Zielny,
Larry Johnson,
Lauren L Vajo,
Lawrence R Johnson,
LCDR Debra Emerson,
Li Li,
Loretta Nemchik,
Mark R Mcclain,
Maya M Davis,
Meisha A Mandal,
Melissa T Roy,
Meyer J Slobotsky,
Michael A Charles,
Michael G Mayfield,
Michael R Klapal,
Mindy M Chou,
Nancy F Scheraga,
Nealie C Newberger,
Nerizza B Guerin,
Nicholas A Violand,
Nicole E Knowlton,
Niketa Patel,
Patrick C Klotzbuecher,
Paul L Bellamy,
Pushpa S Jayasekara,
Rachael A Moliver,
Rebecca B Welch,
Regina T Brown,
Robert J Martin,
Roger F Zabinski,
Rose Ljean Mary,
Russell J Glapion,
Satheesh K Podaralla,
Sean R Marcsisin,
Stephen J Mottola,
Steve Y Rhieu, PhD,
Unnee Ranjan,
Victoria Spivak,
Yong Wang,
Yumi J Hiramine,
Yvesna C Blaise,
Zhongren Wu
Samir C Gala's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2022 | FDA 483 | American Distilling Inc. - Form 483, 2022-04-26 |
March, 2022 | FDA 483 | Centrix Inc - Form 483, 2022-03-02 |
March, 2021 | EIR | PINE LAKE INVESTMENTS, INC. - EIR, 2021-03-18 |
August, 2022 | FDA 483 | RK PHARMA INC. - Form 483, 2022-08-12 |
July, 2021 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2021-07-28 |
June, 2022 | FDA 483 | Hikma Injectables USA Inc. - Form 483, 2022-06-08 |
October, 2022 | FDA 483 | Unipharm, Inc - Form 483, 2022-10-05 |
January, 2023 | FDA 483 | Miyoshi America, Inc. - Form 483, 2023-01-13 |
March, 2020 | FDA 483 Response | Edge Pharma, LLC - Form 483R, 2020-05-01 |
May, 2021 | FDA 483 | Miyoshi America, Inc. - Form 483, 2021-05-25 |
March, 2020 | FDA 483 | Edge Pharma, LLC - Form 483, 2020-03-30 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more